Ovarian Cancer Treatment with Dendritic Cell Vaccines
Ovarian cancer remains one of the most challenging malignancies in gynecologic oncology. Often diagnosed at an advanced stage, it is the fifth leading cause of cancer-related death among women in the Western world. According to the American Cancer Society, over 20,000 new cases of ovarian cancer will be diagnosed in the...
Survival for breast cancer
Breast cancer is a disease that can lead to fatality. However, it can be fatal only if it has not been treated on time. In recent years, doctors have learned how to manage this pathology effectively. As a result, there is now a high survival rate among patients, especially in developed countries. Many effective methods of breast cancer treatment...
Renal Cell Carcinoma Treatment with Dendritic Cell Therapy
Renal cell carcinoma (RCC) accounts for approximately 90% of all kidney cancers and remains one of the ten most common cancers worldwide. In 2022 alone, more than 435,000 new cases were diagnosed globally, with over 156,000 deaths attributed to the disease. The incidence has been steadily increasing, particularly in high-income...
Liver Cancer Treatment with Dendritic Cell Therapy
Liver cancer remains one of the most pressing global health challenges of the 21st century. It is the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for the vast majority of cases. According to the Global Cancer Observatory, over 900,000 new liver cancer cases were diagnosed in 2022 alone...
Multiple Myeloma Treatment with Dendritic Cell Therapy
Multiple myeloma is a malignant blood disorder that affects plasma cells - white blood cells responsible for producing antibodies. This type of cancer typically develops in the bone marrow and can lead to bone damage, anemia, kidney failure, and a weakened immune system. Although it remains incurable, the last decade has brought significant...
Innovative Breast Cancer Care: A Look Inside German Top 10 Hospitals
Breast cancer is currently the most common cancer among women worldwide, with approximately 2.3 million new cases and 670,000 deaths reported in 2022 alone. Early detection and timely breast cancer treatment are crucial – if managed in the early, localized stage, the five-year survival rate can reach nearly 99%. Cancer treatment in Germany is known...
Dendritic Cell Immunotherapy for Non-Small Cell Lung Cancer
Non-small cell lung cancer affects 85% of lung cancer patients, with stage III-IV cases having less than 5% five-year survival rates. While traditional treatments help only 30% of selected patients, innovative dendritic cell immunotherapy shows 50-65% effectiveness rates in clinical studies. These "immune system generals" train your body to fight...
Brain Astrocytoma Treatment – Full Guide: All New Astrocytoma Treatment Options
Astrocytoma is a type of glioma originating from star-shaped astrocyte cells in the brain, ranging from relatively slow‑growing (grades I–III) to the highly aggressive grade IV form, glioblastoma. In the U.S., gliomas occur at about 6 cases per 100,000 people annually, with glioblastoma accounting for approximately 61 % of those and...
